Raymond James & Associates’s Xtrackers MSCI EAFE Hedged Equity ETF DBEF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$23M Buy
547,547
+330,329
+152% +$13.6M 0.01% 745
2024
Q2
$9M Buy
217,218
+3,915
+2% +$161K 0.01% 1226
2024
Q1
$8.73M Buy
213,303
+7,362
+4% +$285K 0.01% 1243
2023
Q4
$7.62M Buy
205,941
+14,437
+8% +$511K 0.01% 1275
2023
Q3
$6.68M Buy
191,504
+26,047
+16% +$915K 0.01% 1277
2023
Q2
$5.85M Sell
165,457
-1,432
-0.9% -$51.5K ﹤0.01% 1377
2023
Q1
$5.87M Sell
166,889
-6,552
-4% -$226K 0.01% 1357
2022
Q4
$5.59M Sell
173,441
-6,715
-4% -$236K 0.01% 1331
2022
Q3
$6.03M Buy
180,156
+16,189
+10% +$578K 0.01% 1241
2022
Q2
$5.71M Buy
163,967
+323
+0.2% +$11.9K 0.01% 1316
2022
Q1
$6.17M Buy
163,644
+27,483
+20% +$1.04M 0.01% 1354
2021
Q4
$5.35M Sell
136,161
-5,037
-4% -$196K ﹤0.01% 1506
2021
Q3
$5.33M Sell
141,198
-30,346
-18% -$1.16M ﹤0.01% 1461
2021
Q2
$6.44M Buy
171,544
+12,929
+8% +$483K 0.01% 1322
2021
Q1
$5.76M Sell
158,615
-31,657
-17% -$1.11M 0.01% 1334
2020
Q4
$6.39M Buy
190,272
+8,008
+4% +$259K 0.01% 1192
2020
Q3
$5.58M Sell
182,264
-27,085
-13% -$833K 0.01% 1162
2020
Q2
$6.33M Sell
209,349
-446,828
-68% -$13M 0.01% 1058
2020
Q1
$17.6M Sell
656,177
-55,024
-8% -$1.73M 0.03% 503
2019
Q4
$24M Buy
711,201
+443,511
+166% +$14.7M 0.03% 504
2019
Q3
$8.66M Sell
267,690
-25,023
-9% -$790K 0.01% 926
2019
Q2
$9.25M Buy
292,713
+95,368
+48% +$3.03M 0.01% 891
2019
Q1
$6.16M Sell
197,345
-59,007
-23% -$1.77M 0.01% 1078
2018
Q4
$7.15M Sell
256,352
-23,989
-9% -$721K 0.01% 919
2018
Q3
$9.07M Sell
280,341
-311,393
-53% -$9.93M 0.01% 881
2018
Q2
$18.6M Buy
591,734
+390,373
+194% +$12.4M 0.03% 531
2018
Q1
$6.18M Sell
201,361
-323,155
-62% -$10.2M 0.01% 1029
2017
Q4
$16.7M Buy
524,516
+78,684
+18% +$2.5M 0.03% 541
2017
Q3
$13.8M Buy
445,832
+15,836
+4% +$480K 0.03% 585
2017
Q2
$12.9M Buy
429,996
+39,174
+10% +$1.19M 0.03% 593
2017
Q1
$11.6M Sell
390,822
-36,434
-9% -$1.05M 0.03% 595
2016
Q4
$12M Buy
427,256
+17,015
+4% +$459K 0.03% 549
2016
Q3
$10.8M Sell
410,241
-105,556
-20% -$2.74M 0.03% 568
2016
Q2
$12.9M Sell
515,797
-104,975
-17% -$2.69M 0.04% 451
2016
Q1
$15.9M Sell
620,772
-1,507,165
-71% -$38M 0.05% 375
2015
Q4
$57.8M Buy
2,127,937
+65,531
+3% +$1.81M 0.21% 104
2015
Q3
$53.8M Sell
2,062,406
-529,068
-20% -$14.9M 0.22% 92
2015
Q2
$74.2M Buy
2,591,474
+1,664,326
+180% +$50.7M 0.28% 65
2015
Q1
$27.8M Buy
927,148
+177,140
+24% +$5.09M 0.12% 176
2014
Q4
$20.3M Buy
750,008
+241,128
+47% +$6.63M 0.1% 224
2014
Q3
$14.1M Buy
508,880
+17,982
+4% +$498K 0.08% 265
2014
Q2
$13.5M Buy
490,898
+267,177
+119% +$7.37M 0.08% 257
2014
Q1
$6.07M Buy
223,721
+145,210
+185% +$3.9M 0.04% 494
2013
Q4
$2.15M Buy
+78,511
New +$2.08M 0.02% 920

Other funds holding DBEF

Raymond James & Associates's DBEF Position: Q3 2024 in Review

Raymond James & Associates increased its Xtrackers MSCI EAFE Hedged Equity ETF (DBEF) stake by 152% in Q3 2024, buying an estimated $13.6M and bringing the position to 547,547 shares worth $23M. The position accounts for 0.01% of the portfolio, ranked #745.

Raymond James & Associates first reported a position in DBEF in Q4 2013 and has held it in 44 quarters since. The position peaked at $74.2M in Q2 2015. 335 funds tracked by Wall St. Rank hold DBEF as of Q3 2024.

  • Raymond James & Associates held 547,547 shares of Xtrackers MSCI EAFE Hedged Equity ETF worth $23M as of Q3 2024.
  • Raymond James & Associates bought 330,329 Xtrackers MSCI EAFE Hedged Equity ETF shares in Q3 2024, an estimated $13.6M.
  • Xtrackers MSCI EAFE Hedged Equity ETF made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #745 holding.
  • Raymond James & Associates first reported a position in Xtrackers MSCI EAFE Hedged Equity ETF in Q4 2013 and has held it in 44 quarters since.
  • Raymond James & Associates's Xtrackers MSCI EAFE Hedged Equity ETF position peaked at $74.2M in Q2 2015.
  • 335 funds tracked by Wall St. Rank held Xtrackers MSCI EAFE Hedged Equity ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.